|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 August 2001, Vol. 98, No. 4, pp. 1116-1121
IMMUNOBIOLOGY
Quantitation of T-cell neogenesis in vivo after allogeneic bone
marrow transplantation in adults
Ephraim P. Hochberg,
Antoinette C. Chillemi,
Catherine J. Wu,
Donna Neuberg,
Christine Canning,
Kelly Hartman,
Edwin P. Alyea,
Robert J. Soiffer,
Spyros A. Kalams, and
Jerome Ritz
From the Disease Center for Hematologic Oncology,
Department of Adult Oncology, Department of Biostatistics, Dana-Farber
Cancer Institute; Department of Medicine, Brigham and Women's
Hospital; Partners AIDS Research Center, Massachusetts General
Hospital; and Harvard Medical School, Boston MA.
Following myeloablative therapy, it is unknown to what extent
age-dependent thymic involution limits the generation of new T cells
with a diverse repertoire. Normal T-cell receptor gene rearrangement in T-cell progenitors results in the generation of T-cell
receptor rearrangement excision circles (TRECs). In this study, a
quantitative assay for TRECs was used to measure T-cell neogenesis in
adult patients with leukemia who received myeloablative therapy
followed by transplantation of allogeneic hematopoietic stem
cells. Although phenotypically mature T cells had recovered by
1 to 2 months after bone marrow transplantation (BMT), TREC levels
remained low for 3 months after BMT. T-cell neogenesis became evident
by 6 months, and normal levels of adult thymic function were restored
at 6 to 12 months after BMT. Subsequent leukemia relapse in some
patients was associated with reduced TREC levels, but infusion of
mature donor CD4+ T cells resulted in rapid restoration of
thymic function. These studies demonstrate that T-cell neogenesis
contributes to immune reconstitution in adult patients and suggest that
thymic function can be manipulated in vivo.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Clave, M. Busson, C. Douay, R. Peffault de Latour, J. Berrou, C. Rabian, M. Carmagnat, V. Rocha, D. Charron, G. Socie, et al.
Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation
Blood,
June 18, 2009;
113(25):
6477 - 6484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dulude, R. Cheynier, D. Gauchat, A. Abdallah, N. Kettaf, R.-P. Sekaly, and S. Gratton
The Magnitude of Thymic Output Is Genetically Determined through Controlled Intrathymic Precursor T Cell Proliferation
J. Immunol.,
December 1, 2008;
181(11):
7818 - 7824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sacre, S. Nguyen, C. Deback, G. Carcelain, J.-P. Vernant, V. Leblond, B. Autran, and N. Dhedin
Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation
J. Virol.,
October 15, 2008;
82(20):
10143 - 10152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Castermans, F. Baron, E. Willems, N. Schaaf-Lafontaine, N. Meuris, A. Gothot, J.-F. Vanbellighen, C. Herens, L. Seidel, V. Geenen, et al.
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning
Haematologica,
February 1, 2008;
93(2):
240 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gorski, X. Chen, M. Gendelman, M. Yassai, A. Krueger, E. Tivol, B. Logan, R. Komorowski, S. Vodanovic-Jankovic, and W. R. Drobyski
Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment
Blood,
June 15, 2007;
109(12):
5502 - 5510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zorn, H. T. Kim, S. J. Lee, B. H. Floyd, D. Litsa, S. Arumugarajah, R. Bellucci, E. P. Alyea, J. H. Antin, R. J. Soiffer, et al.
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
Blood,
October 15, 2005;
106(8):
2903 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Aujesky, K. J. Smith, J. Cornuz, and M. S. Roberts
Cost-Effectiveness of Low-Molecular-Weight Heparin for Treatment of Pulmonary Embolism
Chest,
September 1, 2005;
128(3):
1601 - 1610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. N. Haining, D. S. Neuberg, H. L. Keczkemethy, J. W. Evans, S. Rivoli, R. Gelman, H. M. Rosenblatt, W. T. Shearer, J. Guenaga, D. C. Douek, et al.
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia
Blood,
September 1, 2005;
106(5):
1749 - 1754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Yamanaka, N. Yawalkar, D. A. Jones, D. Hurwitz, K. Ferenczi, S. Eapen, and T. S. Kupper
Decreased T-Cell Receptor Excision Circles in Cutaneous T-Cell Lymphoma
Clin. Cancer Res.,
August 15, 2005;
11(16):
5748 - 5755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, R. Barfield, E. Benaim, W. Leung, J. Knowles, D. Lawrence, M. Otto, S. A. Shurtleff, G. A. M. Neale, F. G. Behm, et al.
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients
Blood,
January 15, 2005;
105(2):
886 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Kayser, F L Alberto, N P da Silva, and L E. Andrade
Decreased number of T cells bearing TCR rearrangement excision circles (TREC) in active recent onset systemic lupus erythematosus
Lupus,
December 1, 2004;
13(12):
906 - 911.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Krenger, H. Schmidlin, G. Cavadini, and G. A. Hollander
On the Relevance of TCR Rearrangement Circles as Molecular Markers for Thymic Output during Experimental Graft-versus-Host Disease
J. Immunol.,
June 15, 2004;
172(12):
7359 - 7367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Quinlan, A. McQuillan, and J. W. Eikelboom
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism: A Meta-Analysis of Randomized, Controlled Trials
Ann Intern Med,
February 3, 2004;
140(3):
175 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zoller
Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host
J. Immunol.,
December 15, 2003;
171(12):
6941 - 6953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Poulin, M. Sylvestre, P. Champagne, M.-L. Dion, N. Kettaf, A. Dumont, M. Lainesse, P. Fontaine, D.-C. Roy, C. Perreault, et al.
Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease
Blood,
December 15, 2003;
102(13):
4600 - 4607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. C. Broers, S. J. Posthumus-van Sluijs, H. Spits, B. van der Holt, B. Lowenberg, E. Braakman, and J. J. Cornelissen
Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants
Blood,
August 15, 2003;
102(4):
1534 - 1540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Orsini, R. Bellucci, E. P. Alyea, R. Schlossman, C. Canning, S. McLaughlin, P. Ghia, K. C. Anderson, and J. Ritz
Expansion of Tumor-specific CD8+ T Cell Clones in Patients with Relapsed Myeloma after Donor Lymphocyte Infusion
Cancer Res.,
May 15, 2003;
63(10):
2561 - 2568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Lewin, G. Heller, L. Zhang, E. Rodrigues, E. Skulsky, M. R. M. van den Brink, T. N. Small, N. A. Kernan, R. J. O'Reilly, D. D. Ho, et al.
Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations
Blood,
August 28, 2002;
100(6):
2235 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zorn, K. S. Wang, E. P. Hochberg, C. Canning, E. P. Alyea, R. J. Soiffer, and J. Ritz
Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells
Clin. Cancer Res.,
July 1, 2002;
8(7):
2052 - 2060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guimond, A. Balassy, M. Barrette, S. Brochu, C. Perreault, and D. C. Roy
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells
Blood,
June 28, 2002;
100(2):
375 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bellucci, E. P. Alyea, E. Weller, A. Chillemi, E. Hochberg, C. J. Wu, C. Canning, R. Schlossman, R. J. Soiffer, K. C. Anderson, et al.
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
Blood,
May 29, 2002;
99(12):
4610 - 4617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Talvensaari, E. Clave, C. Douay, C. Rabian, L. Garderet, M. Busson, F. Garnier, D. Douek, E. Gluckman, D. Charron, et al.
A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation
Blood,
February 15, 2002;
99(4):
1458 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|